MariMed Q2 Interview Focuses On Margins, Distribution And Federal Readiness

MariMed executives told The Dales Report that second-quarter revenue reached $41.9 million as wholesale and retail revenue increased sequentially and adjusted gross margin held at 40 percent, figures corroborated by the company's earnings release. The discussion of GMP preparation, DEA inspections and pricing pressure gives Oklahoma operators a practical benchmark for protecting margins while preparing facilities for tighter federal standards.